Value proposition

Improving human health through Artificial Intelligence - Accelerating drug discovery in small molecules and degraders

Kantify is a TechBio company, using AI to discover breakthrough therapies that change patients' lives.
Our cutting-edge AI platform, Sapian, identifies promising drugs for any disease target, with lightning speed and unprecedented performance.

Contact us for a first discussion.

#biotech #artificialintelligence

artificial intelligence, machine learning, deep learning, drug discovery, targeted protein degraders, small molecules, target identification, and cancer